27 results
8-K
EX-99.1
SIGY
Sigyn Therapeutics, Inc.
8 Jan 24
Regulation FD Disclosure
2:34pm
include community-acquired pneumonia, drug-resistant viral & bacterial infections, endotoxemia, and sepsis, the leading cause of hospital deaths
8-K
EX-99.1
SIGY
Sigyn Therapeutics, Inc.
4 Oct 23
Sigyn Therapeutics™ Discloses PCT Patent Submission to Enhance Chemotherapy Delivery and Reduce Cancer Treatment Toxicity
5:10pm
. Candidate treatment indications include community-acquired pneumonia, drug-resistant virus and bacterial infections, endotoxemia, and sepsis
8-K
EX-99.1
r3q1bd0e
13 Apr 23
Sigyn Therapeutics™ Announces Appointment of
4:03pm
8-K
4do sjf8xb5l3c
9 Mar 22
Entry into a Material Definitive Agreement
4:16pm